UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+0.05%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.52B
AUM Growth
+$53.7M
(+1.5%)
Cap. Flow
-$42.8M
Cap. Flow
% of AUM
-1.22%
Top 10 Holdings %
Top 10 Hldgs %
49.92%
Holding
595
New
104
Increased
143
Reduced
92
Closed
93
Top Buys
Top Sells
Sector Composition
| 1 | Energy | 26.72% |
| 2 | Technology | 21.14% |
| 3 | Healthcare | 14.79% |
| 4 | Industrials | 8.25% |
| 5 | Materials | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
JD.com
JD
$44.6B
| $452K | 0.01% |
+17,500
| New | +$452K |
|
352
Etsy
ETSY
$5.36B
| $442K | 0.01% |
7,500
-55,000
| -88% | -$3.24M |
|
353
Affirm
AFRM
$28.4B
| $438K | 0.01% |
14,500
-4,000
| -22% | -$121K |
|
354
Roku
ROKU
$14B
| $420K | 0.01% |
+7,000
| New | +$420K |
|
355
AMC Entertainment Holdings
AMC
$1.41B
| $388K | 0.01% |
77,868
-29,887
| -28% | -$149K |
|
356
Schrodinger
SDGR
$1.41B
| $387K | 0.01% |
20,011
-5,895
| -23% | -$114K |
|
|
SLRN
357
DELISTED
ACELYRIN
SLRN
| $359K | 0.01% |
81,412
+10,000
| +14% | +$44.1K |
|
358
Sprout Social
SPT
$891M
| $357K | 0.01% |
10,000
-125,000
| -93% | -$4.46M |
|
359
Aligos Therapeutics
ALGS
$78.8M
| $350K | 0.01% |
40,000
+20,000
| +100% | +$175K |
|
360
Netflix
NFLX
$529B
| $337K | 0.01% |
500
-3,500
| -88% | -$2.36M |
|
361
Cardiff Oncology
CRDF
$144M
| $333K | 0.01% |
+150,000
| New | +$333K |
|
|
CRGX
362
DELISTED
CARGO Therapeutics
CRGX
| $328K | 0.01% |
+20,000
| New | +$328K |
|
363
Expedia Group
EXPE
$26.6B
| $328K | 0.01% |
2,600
-27,400
| -91% | -$3.45M |
|
364
Minerva Neurosciences
NERV
$16.4M
| $319K | 0.01% |
99,856
+212
| +0.2% | +$676 |
|
365
Sarepta Therapeutics
SRPT
$1.96B
| $316K | 0.01% |
2,000
-4,813
| -71% | -$760K |
|
366
CG Oncology
CGON
$2.52B
| $316K | 0.01% |
+10,000
| New | +$316K |
|
367
Verastem
VSTM
$663M
| $299K | 0.01% |
100,389
+54,157
| +117% | +$161K |
|
368
Leap Therapeutics
LPTX
$11.7M
| $294K | 0.01% |
149,772
+42,360
| +39% | +$83K |
|
369
Snap
SNAP
$12.4B
| $291K | 0.01% |
+17,500
| New | +$291K |
|
370
SCYNEXIS
SCYX
$37.3M
| $291K | 0.01% |
145,283
+3,552
| +3% | +$7.1K |
|
371
Twilio
TWLO
$16.7B
| $284K | 0.01% |
5,000
-27,500
| -85% | -$1.56M |
|
372
Altimmune
ALT
$334M
| $266K | 0.01% |
40,000
-16,795
| -30% | -$112K |
|
373
Outlook Therapeutics
OTLK
$41.5M
| $266K | 0.01% |
+36,000
| New | +$266K |
|
|
AKTS
374
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $264K | 0.01% |
+2,000,000
| New | +$264K |
|
375
Neurogene
NGNE
$285M
| $258K | 0.01% |
+7,100
| New | +$258K |
|